Didactics-ConCerv Trial: Conservative Management of Early Cervical Cancer

ConCerv Trial: Conservative Management of Early Cervical Cancer

Video Transcription

Video Summary

In this video, the speaker expresses gratitude for the participants' enthusiasm and involvement in Echoes from Russia in 2021. They specifically thank the team from IGCS for their contribution. The speaker discusses the CONSERVE trial, which explores the possibility of using less invasive surgery for patients with early cervical cancer. Initially, there was controversy and concern about deviating from the standard of care, but evidence suggested that less invasive procedures could be suitable for low-risk patients. The CONSERVE trial, along with two other studies, aimed to evaluate the safety and feasibility of conservative surgery for early cervical cancer. The study enrolled 100 patients over a period of nine years. The results showed low recurrence rates and demonstrated that conservative surgery is safe and feasible for low-risk patients. However, further studies are still needed to assess the long-term outcomes and define the criteria for low-risk patients. The SHAPE trial and GOG-278 trial are additional studies expected to shed more light on this topic.

Asset Subtitle

Pedro Ramirez
December 2021

Keywords

CONSERVE trial

less invasive surgery

early cervical cancer

low-risk patients

safety

feasibility